These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1517554)

  • 41. Functional connectivity in fronto-subcortical circuitry during the resting state in obsessive-compulsive disorder.
    Jang JH; Kim JH; Jung WH; Choi JS; Jung MH; Lee JM; Choi CH; Kang DH; Kwon JS
    Neurosci Lett; 2010 May; 474(3):158-162. PubMed ID: 20302914
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serotonin in obsessions, compulsions, and the control of aggressive impulses.
    Insel TR; Zohar J; Benkelfat C; Murphy DL
    Ann N Y Acad Sci; 1990; 600():574-85; discussion 585-6. PubMed ID: 2252336
    [No Abstract]   [Full Text] [Related]  

  • 43. Brain corticostriatal systems and the major clinical symptom dimensions of obsessive-compulsive disorder.
    Harrison BJ; Pujol J; Cardoner N; Deus J; Alonso P; López-Solà M; Contreras-Rodríguez O; Real E; Segalàs C; Blanco-Hinojo L; Menchon JM; Soriano-Mas C
    Biol Psychiatry; 2013 Feb; 73(4):321-8. PubMed ID: 23200527
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Has OCD research gone to the dogs? Comments on "Recent advances in obsessive-compulsive disorder".
    Insel TR
    Neuropsychopharmacology; 1991 Aug; 5(1):13-7; discussion 21-2. PubMed ID: 1930607
    [No Abstract]   [Full Text] [Related]  

  • 45. Association between genetic variants of serotonergic and glutamatergic pathways and the concentration of neurometabolites of the anterior cingulate cortex in paediatric patients with obsessive-compulsive disorder.
    Ortiz AE; Gassó P; Mas S; Falcon C; Bargalló N; Lafuente A; Lázaro L
    World J Biol Psychiatry; 2016 Aug; 17(5):394-404. PubMed ID: 26505676
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Critique of reductionistic models of obsessive-compulsive disorder: toward a new explanatory paradigm.
    Franzblau SH; Kanadanian M; Rettig E
    Soc Sci Med; 1995 Jul; 41(1):99-112. PubMed ID: 7667677
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine.
    Goodman WK; Price LH; Delgado PL; Palumbo J; Krystal JH; Nagy LM; Rasmussen SA; Heninger GR; Charney DS
    Arch Gen Psychiatry; 1990 Jun; 47(6):577-85. PubMed ID: 2112374
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Obsessive-compulsive behaviour: a disorder of decision-making.
    Sachdev PS; Malhi GS
    Aust N Z J Psychiatry; 2005 Sep; 39(9):757-63. PubMed ID: 16168033
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Specificity of performance monitoring changes in obsessive-compulsive disorder.
    Endrass T; Ullsperger M
    Neurosci Biobehav Rev; 2014 Oct; 46 Pt 1():124-38. PubMed ID: 24747486
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Brain activation during response interference in twins discordant or concordant for obsessive compulsive symptoms.
    den Braber A; van 't Ent D; Cath DC; Veltman DJ; Boomsma DI; de Geus EJ
    Twin Res Hum Genet; 2012 Jun; 15(3):372-83. PubMed ID: 22856371
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Biological pathogenesis of obsessive-compulsive disorder].
    Kitabayashi Y; Yoshida T; Kishikawa Y; Fukui K; Taga C
    Ryoikibetsu Shokogun Shirizu; 2003; (38):434-7. PubMed ID: 12877020
    [No Abstract]   [Full Text] [Related]  

  • 52. Altered connectivity within and between the default mode, central executive, and salience networks in obsessive-compulsive disorder.
    Fan J; Zhong M; Gan J; Liu W; Niu C; Liao H; Zhang H; Yi J; Chan RCK; Tan C; Zhu X
    J Affect Disord; 2017 Dec; 223():106-114. PubMed ID: 28743059
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antidepressant-induced mania in obsessive-compulsive disorder.
    Vieta E; Bernardo M
    Am J Psychiatry; 1992 Sep; 149(9):1282-3. PubMed ID: 1503154
    [No Abstract]   [Full Text] [Related]  

  • 54. Altered resting state functional connectivity patterns of the anterior prefrontal cortex in obsessive-compulsive disorder.
    Li P; Li S; Dong Z; Luo J; Han H; Xiong H; Guo Z; Li Z
    Neuroreport; 2012 Aug; 23(11):681-6. PubMed ID: 22692554
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neurosurgical treatment for refractory obsessive-compulsive disorder: implications for understanding frontal lobe function.
    Mindus P; Rasmussen SA; Lindquist C
    J Neuropsychiatry Clin Neurosci; 1994; 6(4):467-77. PubMed ID: 7841817
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Monozygotic twins with obsessive-compulsive disorder.
    Kim SW; Dysken MW; Kline MD
    Br J Psychiatry; 1990 Mar; 156():435-8. PubMed ID: 2346850
    [No Abstract]   [Full Text] [Related]  

  • 57. Sertraline in obsessive-compulsive disorder: a double-blind comparison with placebo.
    Jenike MA; Baer L; Summergrad P; Minichiello WE; Holland A; Seymour R
    Am J Psychiatry; 1990 Jul; 147(7):923-8. PubMed ID: 2192564
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Neuroimaging the various symptom dimensions of obsessive-compulsive disorder].
    Dold M; Aigner M
    Neuropsychiatr; 2009; 23(4):193-205. PubMed ID: 19909691
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Special Issue on Disease: New Advances in Psychiatry.
    Konen C; Niederst E
    Neuron; 2019 Apr; 102(1):12. PubMed ID: 30946817
    [No Abstract]   [Full Text] [Related]  

  • 60. Relief of obsessive-compulsive symptoms by LSD and psilocin.
    Leonard HL; Rapoport JL
    Am J Psychiatry; 1987 Sep; 144(9):1239-40. PubMed ID: 3631327
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.